Class IIITerminated in FDA datasetJun 11, 2012

Erosyn bottles of 30 tablets taken orally Nokomis Research Inc Bell Lifestyle Products #7

Recalling firm: H & L Jerch Sales, Inc.

Why it was recalled

The products contain synthetic equivalents of spermine and/or spermidine, which are constituents or extracts of an herb or other botanical, and the that a synthetic copy of a constituent or extract of an herb or other botanical is not a dietary ingredient, and such ingredients must be approved for use in supplements. The use has not been approved.

Check the codes ↓

The exact product

Erosyn bottles of 30 tablets taken orally Nokomis Research Inc Bell Lifestyle Products #7

Check the codes

Compare these FDA-provided codes, lot numbers or dates with the product you have.

Match the product, size and code together. A similar name alone does not identify your batch.

Original FDA code information

Catalog number: #7: UPC 771733109017; and lot numbers: 11155, 11190, and 12102.

TypeCode / valueContext
UPC771733109017Catalog number: #7: UPC 771733109017; and lot numbers: 11155, 11190, and 12102.

Recall details

Recall number
F-1730-2012
Event ID
61842
FDA status
Terminated
Initiated
Jun 11, 2012
Reported
Jul 18, 2012
Classified
Jul 6, 2012
Terminated
Feb 12, 2013
Quantity
8260 bottles
Location
South Haven, MI, United States
Initiation type
Voluntary: Firm initiated
Notification
Letter

Where it was distributed

Nationwide

FDA source record · F-1730-2012

Data updated September 16, 2026. View official FDA data ↗

A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.